# A Study to Evaluate the Performance of INSTI® HIV Self Test When Performed by Unobserved Intended Users in the US

> **NCT07061912** · NA · COMPLETED · sponsor: **bioLytical Laboratories** · enrollment: 122 (actual)

## Conditions studied

- Human Immunodeficiency Virus I Infection
- Human Immunodeficiency Virus II Infection

## Interventions

- **DEVICE:** NSTI® HIV Self-Test

## Key facts

- **NCT ID:** NCT07061912
- **Lead sponsor:** bioLytical Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-07-24
- **Primary completion:** 2025-08-06
- **Final completion:** 2025-08-06
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2025-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07061912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07061912, "A Study to Evaluate the Performance of INSTI® HIV Self Test When Performed by Unobserved Intended Users in the US". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT07061912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*